thesis-toulmin
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q33441143-E4758A91-63D8-409C-BA30-36B32644A3A9
Q33441143-E4758A91-63D8-409C-BA30-36B32644A3A9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33441143-E4758A91-63D8-409C-BA30-36B32644A3A9
First-in-human trial of multikinase VEGF inhibitor regorafenib and anti-EGFR antibody cetuximab in advanced cancer patients.
P2860
Q33441143-E4758A91-63D8-409C-BA30-36B32644A3A9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33441143-E4758A91-63D8-409C-BA30-36B32644A3A9
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
287b5891b4b325d523261991cd1d3c2dccbb5b92
P2860
ZD1839 (Iressa) induces antiangiogenic effects through inhibition of epidermal growth factor receptor tyrosine kinase.